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RESUMO 
A peroxina 5 (PEX5) é um recetor vaivém responsável pelo transporte de proteínas 
sintetizadas de novo destinadas para a matriz do peroxissoma. Tem uma estrutura 
modular caracterizada por i) um domínio N-terminal pobre em estrutura 
secundária/terciária que contém repetições de pentapéptidos aromáticos e uma cisteína 
evolucionariamente conservada, e ii) um domínio C-terminal conservado e estruturado 
constituído por várias repetições tetratricopeptídicas (TPRs). Depois de interagir com 
proteínas detentoras de uma sequência sinal de direcionamento para o peroxissoma 
(“peroxisomal targeting signal”; PTS), a PEX5 interage com o chamado 
“docking/translocation module” (DTM). Esta interação é dependente dos motivos 
aromáticos existentes na PEX5, e resulta, em última instância, na translocação da 
proteína-cliente para a matriz do organelo. No DTM, a PEX5 é monoubiquitinada na 
cisteína, e posteriormente extraída para o citosol pelo chamado “receptor export module” 
(REM). Estes dois últimos passos são ambos dependentes de ATP. A via de importação 
proteica mediada pela PEX5 é, obviamente, regulada. Presentemente, acredita-se que 
o mecanismo regulatório reside na própria PEX5. De facto, existe alguma evidência 
experimental sugerindo que a metade N-terminal da PEX5 (onde residem os domínios 
de interação com o DTM) interage com a parte C-terminal da PEX5, e que a interação 
de uma proteína-cliente com a região C-terminal da PEX5 destrói esta interação 
intramolecular ativando o seu domínio N-terminal. De acordo com este modelo, foi 
mostrado que uma PEX5 truncada (sem o domínio dos TPRs) é constitutivamente ativa, 
inserindo-se no DTM num processo que é independente de proteínas-cliente. 
O objetivo deste trabalho foi adquirir mais informação sobre a estrutura/função da 
metade N-terminal da PEX5. Utilizando um sistema de importação/exportação in vitro, 
conseguimos demonstrar que um domínio compreendendo apenas os aminoácidos 1 a 
117 da PEX5 tem a capacidade de interagir produtivamente com o DTM, ser 
monoubiquitinado e exportado para o citosol, num processo ATP-dependente, pelo 
REM. De igual forma, a remoção dos 9 resíduos iniciais da PEX5, que são conservados 
em várias espécies, resulta numa molécula perfeitamente funcional nos passos de 
“docking”, inserção, ubiquitinação e exportação. Apesar deste domínio da PEX5 
apresentar funcionalidade nos ensaios in vitro, moléculas de PEX5 que não possuam 
estes resíduos são ainda capazes de se inserirem no DTM de uma forma específica. De 
facto, os nossos dados mostram que uma PEX5 sem os primeiros 137 aminoácidos tem 
a capacidade de se inserir no DTM num passo que é dependente de proteínas-cliente. 
Tal observação sugere que o mecanismo auto-regulatório da PEX5 não reside nos seus 
primeiros 137 aminoácidos. Uma truncagem N-terminal na PEX5 ligeiramente maior, 
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i.e., uma PEX5 sem os primeiros 147 aminoácidos, resulta numa proteína incapaz de 
se inserir no DTM, sugerindo assim, que para moléculas de PEX5 que contenham a 
metade C-terminal, os aminoácidos 138 a 147 são essenciais para o passo de inserção. 
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ABSTRACT 
 Peroxin 5 (PEX5) is a shuttling receptor responsible for the transport of de novo 
synthesized proteins that are destined for the peroxisome matrix. PEX5 has a modular 
structure characterized by i) an N-terminal half with little secondary/tertiary structure that 
contains aromatic pentapeptide repeats and an evolutionary conserved cysteine and, ii) 
a conserved and structured C-terminal half composed by several tetratricopeptide 
repeats (TPRs). After interacting with proteins harbouring a peroxisomal targeting signal 
(PTS), PEX5 interacts with the so-called docking/translocation module (DTM). This 
interaction is dependent on the PEX5 aromatic motifs, and results, ultimately, in the 
translocation of cargo-proteins into the organelle matrix. Then, DTM-embedded PEX5 is 
monoubiquitinated at the cysteine, and extracted into the cytosol by the so-called 
receptor export module (REM). These last two steps are both dependent on ATP. The 
PEX5-mediated protein import pathway is, obviously, regulated. Presently, it is believed 
that the regulatory mechanism resides on PEX5 itself. In fact, there is some experimental 
evidence suggesting that the N-terminal half of PEX5 (where the DTM interaction motifs 
are located) interacts with its C-terminal half. Furthermore, the interaction of a cargo 
protein with the C-terminal region of PEX5 destroys this intramolecular interaction, 
therefore activating its N-terminal domain. In agreement with this model, it has been 
shown that a truncated PEX5 (without the TPRs domain) is constitutively active, being 
inserted into the DTM in a cargo-protein independent process. 
The purpose of this work was to gather more information about the 
structure/function of the PEX5 N-terminal half. By resorting to an in vitro import/export 
system, we demonstrate that a domain harbouring just the PEX5 amino acid residues 1 
to 117 has the capacity to productively interact with the DTM, to be monoubiquitinated 
and exported into the cytosol, in an ATP-dependent process, by the REM. Similarly, the 
removal of the initial 9 residues of PEX5, which are conserved among several species, 
results in a perfectly competent molecule in the docking, insertion, ubiquitination and 
export steps. Although this PEX5 N-terminal domain is functional in the in vitro assays, 
PEX5 molecules that do not contain these residues are still capable of being inserted 
into the DTM in a specific manner. In fact, our data shows that a PEX5 lacking the first 
137 amino acid residues can be inserted into the DTM in a cargo-dependent process. 
This observation suggests that the PEX5 auto-regulatory mechanism does not reside in 
its first 137 amino acid residues. A slightly longer N-terminal PEX5 truncation, i.e., a 
PEX5 without the first 147 amino acid residues, results in a protein incapable of being 
inserted into the DTM, thus suggesting that for PEX5 molecules containing the C-
terminal half, amino acid residues 138 to 147 are essential for the insertion step. 
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 The Peroxisome 
In 1966, de Duve and Baudhuin subjected a rat liver homogenate to a sucrose 
gradient centrifugation and identified microbodies containing high amounts of catalase 
and oxidative enzymes [1]. These cellular entities were termed “peroxisomes” for their 
production and detoxification of hydrogen peroxide. They are characterized by a globular 
shape with 0.1 to 1 µm in diameter and display a dense granular matrix occasionally 
containing a dense crystalloid core when analysed by electron microscopy (see Fig. 1) 
[1,2].  
Peroxisomes are found in nearly all eukaryotic cells. Their number, size and 
function may vary according to the organism, cell type and both internal and exogenous 
signals [3]. There even are some specialized types of peroxisomes that receive other 
names, for instance, fungal Woronin-bodies, which protect against cell leakage after 
hyphal damage [4], plant glyoxysomes, which are responsible for carbohydrate 
anabolism [5], and trypanosomatid glycosomes that perform glycolysis [6].  
The peroxisomal matrix harbours enzymes responsible for more than 50 activities. 
In humans, these activities include the elimination of reactive oxygen species, the 
biosynthesis of ether-phospholipids and bile acids, the β-oxidation of very long chain 
fatty acids (VLCFA) and fatty acid α-oxidation [7]. 
 Peroxisomes and disease 
The correlation between peroxisomes and human disease was described in 1973 
when it was reported that cells from Zellweger patients did not contain visible 
peroxisomal structures [8]. Presently, many peroxisome-associated diseases are known. 
Fig. 1 - Electron micrographs of peroxisomes. 
Left - Longitudinal section of a rat hepatocyte showing one single-membrane bound organelle with a granular matrix and 
a central core. From [1], (X 75,000). 
Right - Trypanosoma brucei glycosome displaying one lipid bilayer and a dense centre, from [6], (X 172,000). 
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Together, they have an incidence of approximately 1:5000 individuals and are generally 
classified into two groups: the peroxisomal single enzyme/transporter deficiencies 
(PEDs) and the peroxisomal biogenesis disorders (PBDs) (reviewed in [9]). PEDs are 
caused by mutations in genes coding for peroxisomal matrix enzymes or membrane-
embedded transporters and affect one or a few peroxisomal metabolic pathways. PBDs 
are the result of mutations in the so-called PEX genes encoding peroxins (or PEX 
proteins), which are proteins essential for peroxisomal biogenesis and inheritance. In the 
most severe cases of PBDs, all peroxisomal metabolic pathways are impaired. 
1.2.1 Peroxisomal biogenesis disorders (PBDs) 
PBDs are a disparate group of autosomal recessive syndromes that are subdivided 
into two categories: the Zellweger syndrome spectrum (ZSS) and the rhizomelic 
chondrodysplasia punctata (RCDP type 1 and type 5) [9]. 
Nowadays, the ZSS comprises four disorders that represent a severity spectrum. 
In an order of decreasing severity, these are: 1) the cerebrohepatorenal syndrome 
(Zellweger disease); 2) the neonatal adrenoleukodystrophy (NALD); 3) the infantile 
Refsum disease (IRD) and 4) the Heimler syndrome (HS) [9]. Clinical manifestations of 
the ZSS include hypotonia, hepatic and/or renal dysfunction, developmental delay, 
craniofacial malformations and seizures [9]. These clinical manifestations are 
accompanied by metabolic alterations such as the accumulation of VLCFA and the 
absence of plasmalogens. At the cell level, these patients may have few or even no 
peroxisomes, or they may contain peroxisomal ghosts (these are organelles deprived of 
matrix proteins) [10]. The Heimler syndrome (HS) is probably the mildest PBD. It is due 
to alterations in PEX1 and PEX6 genes and is characterized by hearing loss and 
abnormalities in teeth’s enamel and nails [11]. Overall, the Zellweger spectrum is 
associated with mutations in 13 PEX genes. These are PEX1, PEX2, PEX3, PEX5, 
PEX6, PEX10, PEX11β, PEX12, PEX13, PEX14, PEX16, PEX19 and PEX26 (see also 
Table 2) [9,10]. 
RCDP shares with ZSS several clinical presentations but reduction of the limbs 
and punctate epiphyseal calcifications are unique to RCDP [9]. RCDP type 1 is due to 
alterations in the gene encoding the peroxin PEX7 [12], which is responsible for the 
import of a small subset of peroxisomal matrix proteins necessary for plasmalogen 
synthesis and the metabolism of phytanic acid [9]. RCDP type 5 was identified in only a 
few patients and arises from a mutation in PEX5 that specifically affects the import of 
proteins recognized by the PEX7 co-receptor (for more details see section 1.3.2.1 and 
1.4) [13]. 
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1.2.2 Peroxisomal single enzyme/transporter deficiencies (PEDs) 
Given that modifications in individual peroxisomal enzymes or transporters lead to 
the impairment of the metabolic pathway where they intervene, PEDs may be classified 
according to the functions affected [14]. The clinical and biochemical phenotypes of 
PEDs are more dispersed. A list of the presently known deficiencies is presented in Table 
1 [9]. 
 Table 1 - List of peroxisomal single enzyme deficiencies. 
 PEDs are listed according to the peroxisomal pathway affected, the modified protein and the gene involved. Adapted 
from [9,15]. 
 Peroxisome Biogenesis 
Currently, 14 mammalian PEX genes have been implicated in the biogenesis and 
inheritance of peroxisomes [13,16]. Peroxisomes lack genetic information and so their 
proteins are encoded on the nuclear DNA, synthesized on the cytosol and delivered to 
their final peroxisomal destination (the organelle membrane or its matrix) [2,17]. 
The biogenesis of the peroxisomal membrane is a controversial issue among the 
scientific community and two models have been proposed: 1) “de novo formation 
Impaired 
peroxisomal 
pathway 
Disease Enzyme/Transporter involved Gene 
Fatty acid  
β-oxidation 
X-linked adrenoleukodystrophy 
(X-ALD) 
ALDP ABCD1 
Acyl-CoA oxidase 1 deficiency ACOX1 ACOX1 
Acyl-CoA oxidase 2 deficiency ACOX2 ACOX2 
D-bifunctional protein 
deficiency 
DBP HSD17B4 
Sterol Carrier Protein X 
deficiency 
SCPx SCP2 
2-Methylacyl-CoA racemase 
deficiency 
AMACR AMACR 
Fatty acid  
α-oxidation 
Refsum disease 
Phytanoyl-CoA 
2-hydroxylase 
PHYH 
Glyoxylate 
metabolism 
Primary Hyperoxaluria type 1 
Alanine:glyoxylate 
aminotransferase (AGT) 
AGXT 
Ether 
phospholipid 
biosynthesis 
RCDP type 2 
Dihydroxyacetonephosphate 
acyltransferase (DHAPAT)  
GNPAT 
RCDP type 3 
Alkyl-
dihydroxyacetonephosphate 
synthase (ADHAPS) 
AGPS 
RCDP type 4 
Fatty acyl-CoA reductase 1 
(FAR1) 
FAR1 
Bile acid 
synthesis 
ABCD3 deficiency PMP70 ABCD3 
BAAT deficiency 
Bile acid-CoA:amino acid  
N-acyltransferase 
BAAT 
Hydrogen 
peroxide 
metabolism 
Acatalasemia Peroxisomal catalase CAT 
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pathway” and 2) the “growth and division model”. The latter proposes that the organelles 
grow and then undergo fission yielding daughter organelles that are replenished with 
new peroxisomal membrane and matrix proteins [2,18,19]. The de novo formation 
pathway is based on the finding that lack of PEX3, PEX16 or PEX19 results in a 
seemingly complete absence of peroxisomes; the reintroduction of the missing 
component leads to the appearance of fully functional peroxisomes, apparently formed 
de novo (reviewed in [16]). 
Regardless of these controversies, it is obvious that from a conceptual point of 
view, biogenesis of an organelle requires 1) formation of the lipid bilayer, 2) insertion of 
peroxisomal membrane proteins (PMPs) into the organelle membrane and, 3) import of 
peroxisomal matrix proteins [16]. 
1.3.1 Peroxisomal membrane assembly 
Peroxisomes do not contain most of the enzymes required for membrane lipid 
biosynthesis. Therefore, they receive them from other sources such as the endoplasmic 
reticulum (ER) [20,21]. In support of this idea, contact sites between these two 
subcellular compartments have been observed by electron microscopy and transfer of 
lipids between them has been documented in yeast [22–24].  
The machinery involved in this lipid transport process remains largely unknown. 
Nevertheless, remodelling of the membrane seems to involve PEX11, which has been 
shown to induce elongation and tubulation of peroxisomes, a process probably coupled 
to the incorporation of new lipids into the peroxisomal membrane [25–29]. In addition to 
lipids, it is obvious that the peroxisomal membrane needs also to be populated with 
proteins to yield a mature and fully functional organelle. How these proteins are targeted 
and inserted into the organelle membrane is still not fully comprehended. Yet, it is clear 
that two integral peroxisomal membrane proteins, PEX3 and PEX16, plus the cytosolic 
chaperone PEX19 are required (reviewed in [16]). According to current models, PEX19 
binds newly synthesized PMPs in the cytosol and delivers them to the membrane 
embedded-PEX3 protein [30–32]. Somehow these interactions culminate with the 
insertion of the PMPs into the peroxisomal membrane and in the release of PEX19 back 
to the cytosol [31,32]. In the specific case of PEX3 and probably also PEX16, the de 
novo synthesis model postulates a different pathway. Indeed, according to some authors 
these proteins are co-translationally inserted into the ER, from where they are then 
directed to the peroxisome [29,33]. 
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1.3.2 The peroxisomal matrix protein import pathway 
Import of peroxisomal matrix proteins requires a unique but extremely conserved 
machinery (see Table 2), the so-called peroxisomal matrix protein import machinery 
(PIM) [34–36]. Impressively, this machinery is capable of internalizing folded and even 
oligomeric proteins [37–39]. Many different strategies have been used to dissect the 
mechanism of the PIM, from in vitro and in vivo functional studies to the isolation and 
analysis of protein complexes. Collectively, the data gathered by many different 
laboratories suggest that this import pathway involves 3 phases: 1) the recognition of a 
cytosolic cargo protein by the shuttling receptor; 2) the docking and insertion of receptor-
cargo protein complex into the peroxisomal membrane with concomitant cargo release 
into the organelle lumen; and, 3) the recycling of the shuttling receptor back to the 
cytosol. Details on of each of these steps are provided below. 
Table 2 - Proteins involved in the peroxisomal matrix protein import pathway, their subcellular localization and 
function. 
Adapted from [40–42]. Abbreviations: Cyt, cytosol; Membr, membrane; M, mammals; P, plants; F, fungi; Y, yeast; PTS1, 
peroxisomal targeting signal 1; PTS2, peroxisomal targeting signal 2; DTM, docking/translocation module; REM, receptor 
export module; Ub-PEX5, monoubiquitinated PEX5; *, proteins associated with other cellular functions and not exclusive 
of the peroxisome biogenesis. 
1.3.2.1 The peroxisomal targeting signals and their receptors 
As previously mentioned, peroxisomal matrix proteins are translated on free 
cytosolic ribosomes and post-translationally transported to their final peroxisomal 
destination [2,34]. In order to be delivered to the peroxisome lumen, these proteins must 
display a peroxisomal targeting signal (PTS) which can be of two types. The majority 
contain a carboxyl(C)-terminal PTS-type 1 (PTS1), which comprises a tripeptide with the 
consensus sequence (S/A/C)-(K/H/R)-(L/M) [43,44]. A small number of matrix proteins 
Protein Localization Organism Purpose 
PEX5 Cyt/Membr M, P, F, Y 
Receptor for PTS1 protein  
Receptor for PTS2 proteins in M & P 
PEX7 Cyt/Membr M, P, F, Y Co-receptor for PTS2 proteins 
PEX13 Membr M, P, F, Y Transmembrane DTM component 
PEX14 Membr M, P, F, Y Transmembrane DTM component 
PEX2 Membr M, P, F, Y E3 ubiquitin-ligase 
PEX10 Membr M, P, F, Y E3 ubiquitin-ligase 
PEX12 Membr M, P, F, Y E3 ubiquitin-ligase 
PEX1 Cyt/Membr M, P, F, Y Receptor export 
PEX6 Cyt/Membr M, P, F, Y Receptor export 
PEX26 Membr M, F, Y REM membrane anchor 
E1* Cyt M, P, F, Y Ubiquitin-activating enzyme 
E2D1/2/3* Cyt M E2 ubiquitin-conjugating enzyme 
AWP1* Cyt M 
Adaptor protein that probably mediates the 
interaction of the REM with Ub-PEX5 
USP9X* Cyt M Desubiquitinase 
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contain instead a PTS-type 2 (PTS2) [45]. This is a degenerated amino(N)-terminal 
nonapeptide characterized by the consensus sequence R-
(L/V/I/Q)XX(L/V/I/H)(L/S/G/A)X(H/Q)(L/A) [46,47]. In contrast to the PTS1, the PTS2 is 
generally cleaved after import [48–52]. In mammals, both PTS1 and PTS2 proteins are 
transported to the peroxisome by the shuttling receptor PEX5 [53–57]. For PTS1-
containg cargoes no protein other than PEX5 is necessary for this process [58–62]. For 
PTS2-proteins, PEX5 needs the help of PEX7, a WD-40 repeat protein which interacts 
both with PEX5 and the PTS2 (see also section 1.4) [49,53,54,56,57,63]. 
1.3.2.2 Docking and translocation of receptor-cargo proteins 
After binding a cargo-protein in the cytosol, the receptor PEX5 interacts with a 
peroxisomal membrane protein complex - the so-called docking/translocation module 
(DTM) - through several conserved motifs present in the PEX5 N-terminal half (see 
section 1.4 and Fig. 2, 1b) [64–69]. The mammalian DTM is composed by PEX14 and 
PEX13, plus a complex of E3 ubiquitin-ligases comprising PEX2, PEX10 and PEX12, 
each containing a RING(really-interesting-new-gene)-Zn2+ binding domain [70–72]. The 
interaction between the complex PEX5-cargo protein and the DTM, occurs in two steps: 
1) docking, and 2) insertion. The first can occur at low temperatures (0 ºC) and is 
completely reversible (PEX5 at this step is referred to as stage 1b PEX5; see Fig. 2); the 
second, on the contrary, is irreversible in the absence of cytosolic ATP and requires 
higher temperatures [34,73,74]. Strikingly, after the insertion step, PEX5 displays a 
transmembrane topology exposing a small N-terminal segment (of ca. 2-kDa) into the 
cytosol, whereas the remaining polypeptide chain faces the matrix side of the membrane. 
This is the so-called stage 2 PEX5 (see Fig. 2) [75–77]. Importantly, experiments using 
an in vitro system, which recapitulates all the steps of the PEX5-mediated protein import 
pathway, have shown that insertion of PEX5 into the DTM is cargo-dependent and ATP-
independent [75,76,78]. These and other findings led to the proposal that the driving 
force for protein translocation across the peroxisomal membrane resides in the strong 
protein-protein interactions that are established between PEX5, on one side, and 
components of the DTM on the other (e.g., PEX14 and PEX13) [34,78,79]. Insertion of 
the PEX5-cargo protein complex into the DTM culminates with the release of the cargo-
protein into the organelle matrix [74,80]. Considering that, in at least some cases, the 
PEX5-cargo protein interaction is very strong (which translates into very high half-lives 
of these complexes) [76,81]; it has been proposed that cargo release is triggered by 
DTM-induced conformational alterations in the receptor [81,82]. 
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1.3.2.3 Monoubiquitination and recycling of the shuttling receptors 
As mentioned above, insertion of PEX5 into the DTM is an irreversible process 
[73,74]. Thus, it is not surprising that disruption of the PEX5-DTM interaction requires 
the chemical energy from ATP hydrolysis [78,83]. Remarkably, the ATP-dependent 
extraction of receptors back into the cytosol comprises two different steps: 1) 
ubiquitination of PEX5 at an evolutionary conserved cysteine present at its N-terminal 
and, 2) extraction of monoubiquitinated-PEX5 (Ub-PEX5) by a peroxisomal protein 
complex, the so-called receptor export module (REM), which comprises the two AAA 
Fig. 2 - The mammalian peroxisomal matrix protein import cycle. 
Schematic representation of the PEX5-mediated peroxisomal protein import, please note that sub-stages “a” and “b” are 
theoretical. For simplicity, PEX7 is not represented. Nevertheless, PEX7 binds cytosolic PTS2-proteins and is escorted 
by PEX5 through the displayed stages of this pathway. Stage 0 - The cytosol contains free PEX5 (5, orange, hand-
shaped), ubiquitin (Ub, green) and newly synthesized cargo proteins (CP, pink). Stage 1a - PEX5 recognizes and binds 
a cargo protein destined for the peroxisomal lumen. Stage 1b - The receptor-cargo complex docks at the DTM peroxins 
(DTM, grey, rectangle). Stage 2 - The PEX5-cargo protein complex gets inserted into the DTM in a cargo- and 
temperature-dependent manner (T>16 ºC). Here, the establishment of strong protein-protein interactions between PEX5 
and the DTM components is suggested to drive translocation and release of the cargo protein into the peroxisomal matrix. 
Stage 3a - Membrane-embedded PEX5 is monoubiquitinated at Cys11 in a process dependent on ATP. Stage 3b - 
Quickly, Ub-PEX5 is recognized by the REM (blue complex). Stage 4 - The REM couples ATP hydrolysis to the removal 
of Ub-PEX5 from peroxisomal membranes. Once again in the cytosol, Ub-PEX5 is deubiquitinated by enzymatic (USP9X) 
and non-enzymatic mechanisms (GSH) yielding a free receptor optimal for further import rounds -Stage 0. 
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ATPases, PEX1 and PEX6, that are anchored to the peroxisomal membrane by the third 
subunit of the REM, PEX26 [73,84–87]. 
Several mechanistic details on each of these steps are already known. 
Monoubiquitination of PEX5 displays some unique properties. Indeed, in contrast to the 
vast majority of ubiquitination reactions occurring in the cell, which involves the formation 
of an isopeptide bond between the carboxyl-terminus of ubiquitin and the ε-amino-group 
of a lysine residue in the targeted proteins, here, the acceptor of ubiquitin is a conserved 
cysteine residue in PEX5 (Cys11 in human PEX5) [84,88,89]. The mammalian E2s 
involved in this conjugation have been identified [90]. These are the E2D1/2/3 ubiquitin-
conjugating enzymes (also known as UbcH5a/b/c in humans). It is presently accepted 
that ubiquitin transthiolation from the E2 to PEX5 is catalysed by the RING-finger 
peroxins, PEX2, PEX10 and PEX12, but which of these three peroxins (if any alone) is 
specifically involved in this event remains completely unknown [55,72,91–93]. 
Monoubiquitination of PEX5 at the DTM is rapidly followed by its ATP-dependent 
extraction by the REM [78,84,85,89,94,95]. Although we are still lacking molecular details 
on this step, recent data suggest that the AAA ATPases may use a threading mechanism 
to remove Ub-PEX5 from the DTM. Indeed, it has been shown that a PEX5 molecule 
fused to a bulky, tightly folded, C-terminal tag is recognized by the REM but only partially 
extracted from the DTM. Seemingly, the REM cannot thread tightly folded domains [96]. 
Once Ub-PEX5 is in the cytosol, it is rapidly deubiquitinated. In fact, Ub-PEX5 was 
never detect in cytosolic fractions from rat liver, indicating that in vivo the deubiquitination 
step is much faster than the extraction of Ub-PEX5 from the DTM [89,97]. Data from our 
laboratory suggests that Ub-PEX5 can be deubiquitinated by two mechanisms [89,97]. 
One, is based on the lability of the thioester link between ubiquitin and PEX5, and 
postulates that small nucleophiles such as glutathione can disrupt this bond. The other, 
involves a deubiquitinase which in human and rat has been identified as USP9X [97]. 
The deubiquitination of PEX5 is the last step of this protein import pathway. The 
receptor can now bind another cargo-protein and promote its transport to the 
peroxisomal lumen [93]. 
 Functional and structural relationships in PEX5 
In mammals, the PEX5 gene actually gives rise to two different PEX5 proteins, the 
so-called PEX5S (S as in short) and PEX5L (L as in long). The two isoforms originate 
from an mRNA alternative splicing mechanism [53]. Both these proteins are competent 
in transporting PTS1-proteins to peroxisomes, but only PEX5L can interact with PEX7 
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and thus, only this isoform of PEX5 can transport PTS2-proteins to the organelle 
[53,54,98]. 
Human PEX5L is a monomeric protein of 639 amino acids, which corresponds to 
a theoretical molecular mass of 70.9 kDa [99,100]. However, the protein migrates with a 
larger apparent molecular mass upon SDS-PAGE due to the fact that it contains very 
few hydrophobic amino acid residues in its polypeptide chain (see also below) [99,101]. 
Structurally, PEX5 comprises two main domains (see Fig. 3). Its C-terminal half 
contains seven tetratricopeptide repeats (TPRs) [58,61,62].This is the most well-
conserved region of PEX5 among species [54,61,102–104]. The TPR repeats of PEX5 
are organized into two clusters – TPR 1 to 3 and TPR 5 to 7 – with TPR4 functioning as 
a hinge that connects them [61,62]. It is this domain of PEX5 that binds the PTS1 signal. 
The C-terminal PTS1 peptide is bound in a pocket formed by the two TPRs clusters (see 
Fig. 3) [62]. Although this is probably the most important binding interface between PEX5 
and PTS1 cargoes, it is surely not the only one. Indeed, a variety of studies have shown 
that the N-terminal half of PEX5, besides interacting with PEX7 and the PTS2 signal, 
also interacts directly with PTS1 cargo proteins [81,82,98,105–109]. 
The second main domain of PEX5 comprises its N-terminal half. A variety of 
biochemical and biophysical experiments have shown that this is a “natively unfolded 
pre-molten globule-like domain” [101]. Proteins in this family can have some secondary 
structure but they lack a stable tertiary fold [110]. Natively unfolded proteins/domains 
display very interesting properties. For instance, many of these proteins have a higher 
Fig. 3 - Functional components of the mammalian peroxisomal protein import receptor PEX5. 
Scheme depicting the PEX5L bimodal configuration: a structured C-terminal (orange box “TPRs”) and a natively unfolded 
N-terminal domain. At the N-terminal there are 8 pentapeptide motifs (7 WxxxF/Y, plus the motif LVAEF) responsible for
the interaction of PEX5 with the DTM components, PEX13 and PEX14. The N-terminal domain of PEX5 also contains a 
PEX7 binding domain (in purple) which is crucial for the targeting of PEX7-PTS2 complexes to peroxisomes. The PTS1-
signal is bound at the C-terminal of PEX5 by two clusters of tetratricopeptide repeats (TPRs 1-3 and 5-7) as shown in the 
three-dimensional (3D) representation of the PEX5-PTS1 complex along the PTS1-peptide axis [62]. “BD” stands for 
binding domain. The colours in the 3D representation of the TPRs domains range from blue to red which corresponds to 
the TPRs 1 to 7. 
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probability to encounter its binding partners because they can use a so-called “fly-
casting” mechanism [111]. It is in this N-terminal domain of PEX5 that resides the 
evolutionary conserved cysteine, the residue that is ubiquitinated at the DTM as 
explained above [84]. It is also in this domain that seven conserved di-aromatic 
pentapeptide repeats with the sequence WxxxF/Y, as well as a less conserved LVxEF 
pentapeptide motif, are found [65,67,68,70,77,102,103,112–114]. We will refer to the 
latter as pentapeptide 0 and to the former as pentapeptides 1 to 7. 
All these pentapeptides interact directly with PEX14 in in vitro binding assays, 
although in vivo only some of them seem to be crucial for peroxisomal matrix protein 
import [67]. The interaction site on PEX14 for these pentapeptides resides in the N-
terminal domain of this protein (amino acids 1-78) [34,112–114]. The KDs for 
pentapeptide-PEX14 interactions have been determined (see Table 3) [113,114]. They 
are all in the low nanomolar range and thus, they might explain why insertion of PEX5 
into the DTM is an irreversible event. In addition to PEX14, some of the pentapeptide 
motifs in PEX5 have also been implicated in the interaction with another DTM 
component, PEX13 [65,69,99,115]. According to Otera et al., the region comprising 
pentapeptide motifs 3 and 4 interacts directly with this membrane peroxin [67]. 
Table 3 - Dissociation constants (KD) for the interaction of the PEX5 pentapeptide motifs with PEX14(1-78). 
Synthetic peptides harbouring the respective pentapeptide repeat (0 to 7) were incubated or not with PEX14-NTD (amino 
acid residues 1-78). The dissociation constants (KD) for these protein complexes were determined by intrinsic tryptophan 
fluorescence measurements (ITF) [114] or by surface plasmon resonance (SPR) [113], the average of these 
measurements is presented. The sequence of the aromatic motifs and their position in PEX5 are displayed in the 2nd 
column. Note that the PEX5 synthetic peptides analysed correspond to broader PEX5 regions, referred in the 4th column. 
 
Although the PEX5-DTM interaction seems to be simply mediated by the small 
pentapeptide motifs on PEX5, insertion of this receptor into the DTM does not just 
happen by simple collision of the two molecular species. Actually, in the absence of 
cargo-proteins, virtually no PEX5 enters the DTM [75]. Strikingly, this cargo-dependent 
insertion of PEX5 into the DTM is only true for the full-length, fully functional protein; 
truncated PEX5 molecules lacking the C-terminal TPRs domain or a PEX5 containing a 
Motif Nº 
Sequence  
(amino acid position) 
Average KD for 
PEX14-NTD (nM) 
PEX5 region analysed / 
technique 
0 LVAEF (62 – 66) 157 1-110 / SPR 
1 WAQEF (118 – 122) 7 113-128 / ITF 
2 WSQEF (140 – 144) 9 135-150 / ITF 
3 WAEEY (159 – 163) 17 154-169 / ITF 
4 WYDEY (184 – 188) 109 179-194 / ITF 
5 WAAEF (243 – 247) 8 238-252 / ITF 
6 WVDQF (257 – 261) 29 252-267 / ITF 
7 WLSDY (308 – 312) 35 303-318 / ITF 
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single missense mutation (N526K) that abolishes its PTS1 binding activity, no longer 
display this property, i.e., they are constitutively active in the insertion step [75,116]. 
These findings strongly suggest that insertion of PEX5 into the DTM is a regulated 
process and that the regulatory mechanism does not rely on the DTM (seemingly, it can 
accept PEX5 species lacking cargo proteins) but rather on PEX5 itself [75]. These data 
are at the basis of a model in which a PTS1-binding domain acts as a cis-acting repressor 
of the N-terminal half of PEX5, the region of the receptor that interacts with the DTM [75]. 
Such a model postulates the existence of a cross-talk between the two main domains of 
PEX5 but the precise regions involved in this intramolecular interaction remain 
completely unknown. 
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Although our knowledge on the mechanism of the peroxisomal protein import 
machinery has increased dramatically in recent years, we are still far from 
comprehending many of its details. Since PEX5 is involved in all the steps of peroxisomal 
matrix import, characterizing its behaviour during this cycle is crucial to better understand 
this biological pathway. It is known that the C-terminal half of PEX5 is important for PTS1-
cargo binding allowing PEX5 to be in an import-competent state. It is also known that the 
N-terminal half is important for: 1) PTS2-protein import, 2) interaction with the DTM and, 
3) extraction of PEX5 from the DTM. This work is centred on the functional 
characterization of the N-terminal half of PEX5. 
The PEX5 autoinhibition model suggests that there is an intramolecular interaction 
between the C-terminal and N-terminal half of cargo-free PEX5, which blocks the DTM-
interacting motifs in the N-terminal of PEX5. Therefore, the first aim of this work was to 
define the minimum domain of PEX5 capable of binding PTS1-cargoes and entering the 
DTM in a specific process. For this purpose, we produced N-terminally truncated PEX5 
molecules and studied their properties in in vitro import assays (note that these PEX5 
proteins do not have cysteine 11 and therefore cannot be recycled back into the cytosol). 
Naturally, this task might also lead to the identification of a PEX5 truncated protein still 
capable of entering the DTM, but now in a cargo-independent manner. The identification 
of such a PEX5 molecule would provide valuable data on the auto-regulatory mechanism 
of PEX5.  
In the second part of this work we wanted to delimit the minimum domain of PEX5 
with the capacity to: 1) enter the DTM and be monoubiquitinated, and, 2) be exported by 
the REM. Thus, several short C-terminally truncated versions of PEX5 were produced 
and characterized using in vitro import assays. Our aim was to better define the binding 
interface(s) between PEX5 on one side, and the DTM and the REM on the other. 
Finally, if the previous tasks led to the identification of two non-overlapping PEX5 
proteins, both capable of entering the DTM but only one of them competent in the export 
step, then we could use these proteins to gather valuable mechanistic information on the 
action of the REM. Specifically, the demonstration that export of a truncated PEX5 
molecule could drive the export of a per se export-incompetent PEX5 species, would 
suggest that the REM acts on the DTM itself. 
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 Homo sapiens PEX5 DNA constructs 
Truncated versions of PEX5 were constructed by polymerase chain reaction (PCR) 
(with either NZYProof DNA polymerase MB14601 or Invitrogen™ Platinum™ Pfx DNA 
Polymerase) using as template pGEM-4-PEX5L(C11K) and pGEM-4-PEX5L(C11A) [89]. 
Both plasmids encode full-length versions of Homo sapiens PEX5L containing the 
missense mutation that replaces cysteine 11 with a lysine (K) or an alanine (A) residue, 
respectively. In these plasmids, the gene of interest was cloned between SalI restriction 
sites which places a guanine both at position -3 and +4 relative to the AUG initiator 
codon, thus providing a stable variation of the Kozak sequence [117]. cDNAs 
corresponding to Hs-PEX5L(C11A) or Hs-PEX5L(C11K) amino acids residues 1 to 61, 
residues 1 to 61 plus three extra C-terminal methionines, residues 1 to 117, residues 1 
to 125, residues 1 to 139, residues 1 to 158, residues 1 to 181 and residues 1 to 197 
were obtained by PCR with the primers presented in Table 4. The same forward primer, 
which anneals at a pGEM-4 region located 67 base pairs upstream the T7 DNA 
polymerase promoter was used to produce all the cDNAs encoding PEX5 C-terminal 
truncations. The amplified DNA fragments were gel-purified (NzyGelPure MB01101), 
quantified by agarose electrophoresis and used in in vitro transcription/translation (IVT). 
pGEM-4-PEX5(C11A)ΔC1 (described in [118]) codes for a protein comprising 
amino acids 1 to 324 of Homo sapiens PEX5 harbouring the mutation C11A. The plasmid 
pGEM-4-PEX5(C11K)ΔC1 (obtained by Doctor Cláudia Grou) encodes residues 1 to 324 
of Homo sapiens PEX5 comprising the C11K mutation (unpublished). The plasmid 
pET28a-PEX5ΔN147 encodes residues 148 to 639 of PEX5 [82]. 
PEX5(C11K)10-324 is a protein that comprises amino acid residues 10 to 324 of 
Homo sapiens PEX5 with an upstream initiator methionine. Its cDNA was obtained by 
PCR using as a template pGEM4-PEX5L(C11K) (see primers in Table 4). The resultant 
PCR product was gel-purified and sequentially digested with XbaI (Fermentas) and SalI 
(Takara), followed by ligation to a pGEM-4 vector (Promega, vector digested with the 
same enzymes) originating pGEM-4-Hs-PEX5(C11K)10-324. 
The cDNA encoding PEX5ΔN137, which is a protein comprising amino acids 138 
to 639 of Homo sapiens PEX5 with an upstream initiator methionine, was amplified from 
pGEM-4-PEX5L(C11K) in order to be inserted in pET23a (Novagen). (see primers in 
Table 4). The gel-purified cDNA was cloned into the pET-23a NdeI and SalI (Takara) 
restriction sites, originating pET23a-Hs-PEX5ΔN137. Protein in vitro synthesis using this 
vector is possible due to the T7 promoter it contains. To produce a recombinant version 
of this protein with a hexahistidine N-terminal tag (His6), both pET23a-Hs-PEX5ΔN137 
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and pET-28a (Novagen) were digested with NdeI and SalI (Takara). This was followed 
by gel-purification and ligation of the two molecules, originating pET28a-His6-Hs-
PEX5ΔN137. To introduce the recognition sequence for TEV (Tobacco Etch Virus) 
protease between the histidine tag and the PEX5 moiety, the pET28a-His6-Hs-
PEX5ΔN137 was digested with NdeI, dephosphorylated with calf intestine phosphatase 
(NEB) and ligated to a linker coding for the recognition sequence of the TEV protease 
(see primers in Table 4). After transformation (see section 3.7) positive clones with single 
insertions of the linker were selected by colony PCR and 3% agarose/TBE gel analysis. 
Clones were sequenced to ensure the correct orientation of the linker. Expression and 
purification of recombinant PEX5ΔN137 was performed by my colleague Ana Dias. 
We used a similar strategy (i.e., an equal procedure to the one for creating pET23a-
Hs-PEX5ΔN137 and pET28a-His6-Hs-PEX5ΔN137) to develop pET23a-Hs-
PEX5(C11K)1-125 and pET28a-His6-Hs-PEX5(C11K)1-125 (see primers in Table 4). 
These latter plasmids encode PEX5(C11K)1-125, which is a protein comprising amino 
acids residues 1 to 125 of human PEX5 harbouring the mutation C11K. However, 
production of this protein in Escherichia coli (E. coli) turn out to be not possible (see 
below). To solve this problem, a strategy of sequence-and-ligation-independent-cloning 
(SLIC) was used to generate the same PEX5 protein fused to a SUMO3 N-terminal 
solubility tag. PCR was performed with primers LP1_F_vector and LP2_R_vector using 
as template pCoofy6 [119], a plasmid possessing a T7 promoter, a Kozak sequence and 
encoding a hexahistidine tag and SUMO3 (see primers in Table 4). The insert 
PEX5(C11K)1-125 was amplified from pGEM-4-PEX5L(C11K) using primers 
LP1_F_PEX5 and LP2_R_PEX5 (see primers in Table 4). Then, 23 ng of DNA insert 
and 100 ng of vector were mixed and incubated with 0.19 mg/mL of Recombinase A and 
RecA buffer (NEB) for 30 minutes at 37 ºC. The reactions were then treated for 1 hour 
at 37 ºC with DpnI and the DNA was transformed into E. coli DH5α competent cells. The 
correct plasmid pCoofy6-His6-SUMO3-PEX5(C11K)1-125 was obtained and 
transformed into competent E. coli BL21(DE3) cells for protein expression. 
Table 4 - List of forward (F) and reverse (R) primers that were used to produce cDNAs or to construct plasmids. 
The sequence of the primers presented is orientated 5’ to 3’. The reverse complement of the stop codon is underlined.. 
In bold are the sequences recognized by the respective restriction enzyme mentioned in the primer’s name. Regions of 
homology for SLIC cloning are double underscored or dashed. (Table continues on the next page). 
cDNA Plasmid 
Primers forward (F) 
and reverse (R)  
Sequence 5' → 3' 
Hs-PEX5(C11K)1-61 
pGEM-4APF GCCCAATACGCAAACCGCCTCTCC 
Pex5_61R TCACTCATCTTCAGAAGCTACTCCCAAAGGCTTGG 
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cDNA Plasmid 
Primers forward (F) 
and reverse (R)  
Sequence 5' → 3' 
Hs-PEX5(C11K)1-61-M3 
pGEM-4APF GCCCAATACGCAAACCGCCTCTCC  
Pex5_61-3M_R TCACATCATCATCTCATCTTCAGAAGCTACTCCCAAAGG 
Hs-PEX5(C11K)1-117 
pGEM-4APF GCCCAATACGCAAACCGCCTCTCC 
Pex5_117R GGCGAGTCAGTTCTCAGACAAGGCCAAGTCTGC 
Hs-PEX5(C11K/A)1-125 
pGEM-4APF GCCCAATACGCAAACCGCCTCTCC 
Pex5_125R GCGAGGTCAAGCTGCAAGAAACTCCTGG 
Hs-PEX5(C11K/A)1-139 
pGEM-4APF GCCCAATACGCAAACCGCCTCTCC 
Pex5_139R GCCGTCAGTCAGTCTCATTATAATCCTGAGTTACATCC 
Hs-PEX5(C11K/A)1-158 
pGEM-4APF GCCCAATACGCAAACCGCCTCTCC 
Pex5_158R GCAAATCAGCGGGCAGGGGACACAGACAAGG 
Hs-PEX5(C11K/A)1-181 
pGEM-4APF GCCCAATACGCAAACCGCCTCTCC 
Pex5_81R GCAAATCAGGTGGCTGTTCCCTCAGG 
Hs-PEX5(C11K)1-197 
pGEM-4APF GCCCAATACGCAAACCGCCTCTCC 
Pex5_197R GATAATCACGTGTGCTGCAGATCCTCCTCAGG 
pGEM-4-Hs-
PEX5(C11K)10-324 
PEX5_DN9F_SalI GGAATAAGTCGACATGGAAAAGGGGGGTGC 
PEX5_324R_XbaI CGGGCAGGTCTAGATCAGTACCCCTTATCATAGGTAGC 
pET-23a-Hs-
PEX5(C11K)1-125 
F_1-125_NdeI GGACACACATATGGCAATGCGGGAGCTGG 
R_1-125_SalI GGCAAGGTCGACTCAAGCTGCAAGAAACTCCTGG 
pET-23a-Hs-
PEX5ΔN137 
F_138-639_NdeI GGAACGCATATGACTGACTGGTCCCAAGAATTCATCTC 
R_138-639_SalI GATAACGTCGACTCACTGGGGCAGGCCAAACATAG 
TEV linker 
F_TEV_NdeI [Phos]TATGGAGAACCTTTATTTCCAGGGCCA 
Rv_TEV_NdeI [Phos]TATGGCCCTGGAAATAAAGGTTCTCCA 
pCoofy6-His6-SUMO3-
PEX5(C11K)1-125 
LP1_F_vector TCCACCGGTCTGCTGCTGGAACAC 
LP2_R_vector CGCCATTAACCTGATGTTCTGGGG 
LP1_F_PEX5 GTGTTCCAGCAGCAGACCGGTGGAATGGCAATGCGG 
LP2_R_PEX5 
CCCCAGAACATCAGGTTAATGGCGTCAAGCTGCAAGAA
ACTCC 
 Synthesis of 35S-labeled proteins 
Plasmids and linear cDNAs encoding the different versions of PEX5 were used for 
in vitro transcription/translation in the presence of EasyTagTM L-[35S]methionine (specific 
activity >1000 Ci/mmol; PerkinElmer) with the TNT® Quick Coupled 
Transcription/Translation System (Promega) according to the manufacturer’s 
instructions. The proteins obtained were analysed by SDS-PAGE and autoradiography. 
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 Production and purification of recombinant proteins 
GST-Ub, a recombinant fusion protein comprising glutathione-S-transferase and 
ubiquitin was obtained as previously described [84].  
Other recombinant proteins used in this work were already available in our 
laboratory. These proteins are: 1) recombinant TPRs [101], a protein comprising PEX5L 
residues 315 to 639; 2) recombinant TPRs(N526K) [116], a protein containing amino 
acids 315 to 639 of PEX5L with the missense mutation N526K; and 3) recombinant 
cSENP2 [120,121], the catalytic domain of SENP2. 
To produce recombinant His6-TEV-PEX5(C11K)1-125 various experimental 
conditions were attempted. These included: induction of E. coli BL21(DE3) cultures for 
3 hours with 1 mM isopropyl β-D-1-thiogalactopyranoside (IPTG) at 37 ºC and induction 
with 10 μM or 1 mM IPTG for 18 hours at 17 ºC. We also tried to pre-induce the 
chaperone machinery of E. coli by incubating bacterial cultures for 30 minutes on ice 
followed by the addition of 2% ethanol and induction with IPTG (0.5 mM for 2 hours at 
37 ºC). Alternatively, bacterial cultures were treated for 5 minutes at 47 ºC before 
proceeding with the IPTG induction (0.5 mM for 2 hours at 37 ºC). The latter two protocols 
were also tested using different bacterial growth stages (OD600nm = 0.6 or 0.9). Protein 
expression was assessed by SDS-PAGE and Western Blot analysis using an anti-His 
antibody (GE Healthcare). Since none of these attempts yielded positive results, we tried 
to produce PEX5(C11K)1-125 from a different expression plasmid, the pCoofy6-His6-
SUMO3-PEX5(C11K)1-125 described above. For this purpose, E. coli BL21(DE3) cells 
carrying this plasmid were induced for 2 hours at 37 ºC with 1 mM IPTG and cooled on 
ice. Next, cells were pelletized by centrifugation at 3500 rpm at 4 ºC for 20 minutes 
(Beckman Avanti J-26 XP, rotor JLA 8.1000). The pellet was resuspended in 20 mL of 
lysis buffer [50 mM Tris pH 8.0, 150 mM NaCl, 1 mM Dithiothreitol (DTT), 1:500 (v/v) 
Phenylmethanesulfonyl fluoride (PMSF) 50 mg/mL, 1:500 (v/v) mammalian protease 
inhibitor cocktail (Sigma), 200 µg/mL lysozyme] and frozen overnight at -80 ºC. Cells 
were thawed, sonicated on ice, and the lysate was centrifuged at 13000 rpm for 20 
minutes at 4 ºC (Thermo Scientific Sorval Legend Micro 17 centrifuge). The supernatant 
was incubated with 400 µL (bed volume) of Ni2+-NTA Sepharose 6 Fast Flow beads (GE 
Healthcare) for 3 hours at 4 ºC with mixing. The non-bound fraction was removed, and 
the beads were washed three times with wash buffer [50 mM phosphate buffer pH 8.0, 
150 mM NaCl]. The protein was eluted with elution buffer [50 mM phosphate buffer pH 
8.0, 150 mM NaCl, 400 mM imidazole] and residual beads were removed by centrifuging 
the protein solution at 13000 rpm for 10 minutes at 4 ºC (Thermo Scientific Sorval Legend 
Micro 17 centrifuge). Concentration of the recombinant protein and buffer exchange to 
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the storage buffer [50 mM Tris pH 8.0, 150 mM NaCl, 1 mM DTT] was achieved using a 
Vivaspin 2 MWCO 10 000 protein concentrator (GE Healthcare), as described recently 
[76]. 
Removal of the His6-SUMO3 moiety from the recombinant protein His6-SUMO3-
PEX5(C11K)1-125 was done by digesting 1.2 milligrams of the purified recombinant 
protein with 1.2 µg of cSENP2 at 25 ºC for 1 hour. The solution was then incubated with 
133 µL (bed volume) of Ni2+-NTA Sepharose 6 Fast Flow beads (GE Healthcare) for 3 
hours at 4 ºC with mixing. After sedimentation of the beads, the non-bound fraction, 
containing the protein of interest was saved. During this procedure, aliquots were 
removed at different steps and analysed by SDS-PAGE to control the purification 
process. 
 Preparation of rat liver post-nuclear supernatant  
A post-nuclear supernatant (PNS) from rat liver was prepared as described before 
[83]. Briefly, livers from overnight fasted Wistar male rats (1-2 months old) were removed 
and homogenized in ice-cold SEM buffer [0.25 M sucrose, 20 mM MOPS-KOH, pH 7.2, 
and 1 mM EDTA-NaOH, pH 8.0 supplemented with 2 μg/ml N-(trans-epoxysuccinyl)-L-
leucine 4-guanidinobutylamide (E-64)]. The homogenate was centrifuged twice at 2200 
rpm for 10 min at 4 °C (SS-34 rotor in a RC5B Sorvall® centrifuge) to yield a post-nuclear 
supernatant fraction which was aliquoted, frozen on liquid nitrogen and stored at -80 ºC. 
The PNS protein concentration was determined by the Bradford method. 
 In vitro import/export experiments 
A typical reaction is performed in a final volume of 100 µL and contains 600 µg of 
PNS protein, and 1 to 3 µL of rabbit reticulocyte lysate (RRL) containing the relevant 35S-
labelled protein in import buffer [0.25 M sucrose, 50 mM KCl, 20 mM MOPS-KOH pH 
7.2, 3 mM MgCl2, 20 µM methionine, 2 µg/mL E-64, and 2 mM GSH, pH 7.2]. Where 
indicated, the reactions were supplemented with 3 mM ATP or 3 mM AMP-PNP, 15 µM 
of bovine ubiquitin (Ub) or GST-Ub, 0.8 µM of HA-Ubiquitin Aldehyde (HA-Ubal) or 2 µM 
of HA-Ubiquitin-vinyl methyl ester (HA-Ub-VME), 1 µM of rTPRs or 1 µM rTPRs(N526K). 
Reactions were incubated at 37 ºC for 20 minutes, unless otherwise specified. In the 
experiments containing AMP-PNP, the PNS was first primed for import by incubating it 
with 0.3 mM ATP at 37ºC for 5 minutes. This step allows for endogenous DTM-
embedded PEX5 to be exported back into the soluble fraction, therefore increasing the 
number of available free DTMs and consequently enhancing the import efficiency of the 
35S-PEX5 proteins [78,80]. 
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Reactions were stopped by putting them on ice. When the aim was to monitor 
import/export of 35S-PEX5 proteins, the reactions were diluted with SEMK buffer (SEM 
buffer containing 80 mM KCl) to 1 mL and centrifuged at 13000 rpm for 20 minutes at 
4 ºC (Thermo Scientific Sorval Legend Micro 17 centrifuge), yielding an organelle pellet 
(P) and a supernatant (S) which corresponds to the cytosolic fraction. Proteins in the 
supernatant fraction from import/export assays were precipitated with TCA by adding 
1/9th of the sample volume of 100% (w/v) TCA and incubating on ice for 30 minutes. 
Precipitated proteins were then recovered by centrifugation (13000 rpm for 20 minutes 
at 4 ºC - Thermo Scientific Sorval Legend Micro 17 centrifuge), washed with 1 mL of 
100% acetone, centrifuged (13000 rpm for 20 minutes at 4 ºC - Thermo Scientific Sorval 
Legend Micro 17 centrifuge) and dried at 37 ºC. 
When the aim was to assess the membrane topology of 35S-labelled PEX5 
proteins, reactions were treated on ice with 400 µg/mL of Proteinase K (PK) for 30 
minutes (unless otherwise indicated). During this incubation, susceptible proteins will be 
degraded only if they are accessible to the protease; if, on the contrary, a given protein 
is inside an intact organelle, it will escape degradation because the protease cannot 
cross the lipid membrane. At the end of the incubation, PK was inactivated with 400 
µg/mL of PMSF, reactions were diluted to 1 mL with SEMK buffer and centrifuged at 
13000 rpm for 20 minutes at 4 ºC (Thermo Scientific Sorval Legend Micro 17 centrifuge). 
Organelle pellets were subjected to precipitation with a 10% (w/v) TCA solution and 
processed as described above. 
 SDS-PAGE and autoradiography 
Protein samples were heated in Laemmli sample buffer [50 mM Tris-HCl pH 8.8, 
6% SDS, 0.017% bromophenol blue, 10% glycerol, 2 mM EDTA-NaOH pH 8.8, 
supplemented with 0.1 M DTT] for 10 minutes at 65 ºC followed by 5 minutes at 90 ºC 
with shaking. The samples were loaded onto SDS polyacrylamide gels using a 
discontinuous electrophoretic system [122]. Gels were blotted onto nitrocellulose 
membranes (AmershamTM ProtranTM 0.45 µM GE Healthcare) using a semi-dry system 
(The W.E.P. Company) according to the manufacturer instructions. The membranes 
were stained with Ponceau S stain [0.026 M Ponceau S, 1.84 M TCA in deionized water], 
dried and exposed to a x-Ray film (Carestream BioMAX MR film, Cat 873 6936). 
 Miscellaneous 
All the recombinant plasmids constructed in this work by standard ligation 
procedures were transformed into NovaBlue GigaSinglesTM Competent Cells (Novagen). 
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Positive clones were identified by colony PCR screening. Plasmid DNA from these 
clones was prepared using NZYMiniprep kit (MB01001) and sequenced (GATC Biotech). 
Western blots were probed with a mouse monoclonal anti-His antibody (GE 
Healthcare 27-4710-01) as the primary antibody, which was detected using alkaline 
phosphatase-conjugated anti-mouse immunoglobulins G (A2429, Sigma).  
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 Experimental approaches 
One of the most powerful experimental tools to dissect the mechanism of the PIM 
is a cell-free in vitro import/export system developed in our laboratory [76,78,83]. In this 
in vitro system, a rat/mouse liver PNS (which contains peroxisomes and cytosolic 
components) is incubated with a radiolabelled reporter protein in an appropriate buffer. 
A variety of reporter proteins can be used in these assays, from PEX5 or mutant versions 
of it, to PEX7, PTS1 and PTS2 proteins [76]. Also, because this is a completely open 
experimental system numerous reagents (e.g., ATP, AMP-PNP) or recombinant proteins 
(e.g., GST-Ub) can be added to these assays [74,76,78,80,118]. Therefore, one can 
obtain rather different but complementary perspectives on how the PIM works 
[70,74,76,78,83,84]. In this work, we used PEX5-centered in vitro import assays to 
dissect the structural/functional relationships in PEX5. When using PEX5 as a reporter 
protein, two experimental readouts are possible. In one, we can assess the fraction of 
PEX5 that was inserted into the DTM by performing protease-protection experiments 
after an in vitro import assay. Two populations of PEX5 can be detected using this 
approach [75,78]. The so-called stage 2 represents a PEX5 molecule having most of its 
polypeptide chain exposed into the peroxisomal lumen, and thus, protease-protected. In 
fact, only a few residues of stage 2 PEX5 can be removed by proteinase K digestion 
when using intact organelles [77,83]. The second DTM-embedded PEX5 population – 
the so-called stage 3 PEX5 – represents monoubiquitinated PEX5 and is completely 
resistant to proteinase K [83,84]. Note that stage 2 and stage 3 PEX5 probably have the 
same membrane topology; the proteinase K resistance of stage 3 PEX5 is best explained 
by a shielding effect exerted by the ubiquitin moiety attached to PEX5 or by the REM 
itself [83,84].  
The second readout is based on the fact that PEX5 is monoubiquitinated only after 
insertion into the DTM and can be exported back into the cytosol provided that the system 
contains ATP; in the presence of non-hydrolysable ATP analogues, such as AMP-PNP 
or ATPγS, monoubiquitination of PEX5 at the DTM is still possible but its export by the 
REM is completely blocked [78,84]. Thus, a simple centrifugation of import reactions to 
separate organelles from the cytosolic phase followed by SDS-PAGE/autoradiography 
of the two fractions (often referred to simply as P (pellet) and S (supernatant)) provides 
valuable information on the functionality of a given PEX5 molecule [76]. 
Monoubiquitination of PEX5 occurs at cysteine 11, which yields a thioester 
ubiquitin-PEX5 conjugate [84]. Thioesters are relatively labile and tend to hydrolyse at 
the alkaline pH of the SDS-PAGE. Also, they are completely destroyed by reducing 
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agents (e.g., DTT and β-mercaptoethanol), complicating the experimental procedure to 
detect them [84]. In 2009 Grou et al., described that a PEX5 mutant protein with the 
cysteine 11 substituted by a lysine (C11K) is fully functional in import, ubiquitination and 
export. PEX5(C11K) was also shown to complement the import of PTS1-cargo proteins 
in PEX5 deficient mouse embryonic fibroblasts [89]. Since ubiquitin is linked to 
PEX5(C11K) by an isopeptide bond (which is not disrupted by reducing agents/alkaline 
pH), most of the proteins used in this work derived from PEX5(C11K) [89]. 
Several truncated PEX5 molecules were produced in this work. In addition to 
various PEX5(C11K) mutant forms, the corresponding C11A versions were also created. 
PEX5 proteins possessing an alanine at position 11 cannot undergo monoubiquitination 
and therefore are not exported back to the cytosol [89]. Thus, they accumulate at 
peroxisomal membrane DTMs even when in vitro assays are performed in the presence 
of ATP. This makes them much easier to detect after protease treatment. The structural 
details of all the different PEX5 molecules used in this work are presented in Fig. 4 and 
Table 5. 
 
Table 5 - Properties of the PEX5 proteins used in this work. 
The molecular weight in kilodaltons (kDa) of each protein was calculated in Protparam [100], the number of amino acid 
residues and pentapeptide motifs that each protein contains are also provided. 
PEX5 protein 
Predicted molecular 
weight (kDa) 
Number of 
Residues 
Pentapeptide 
motifs 
PEX5(C11K)1-61 6.397 61 ------------ 
PEX5(C11K)1-61-M3 6.790 64 ------------ 
PEX5(C11K)1-117 12.62 117 0 
PEX5(C11K/A)1-125 13.54 125 0,1 
PEX5(C11K/A)1-139 15.06 139 0,1 
PEX5(C11K/A)1-158 17.19 158 0,1,2 
PEX5(C11K/A)1-181 19.87 181 0,1,2,3 
PEX5(C11K/A)1-197 21.98 197 0,1,2,3,4 
PEX5(C11K/A)1-324 36.17 324 0,1,2,3,4,5,6,7 
PEX5L(C11A/K) 70.90 639 0,1,2,3,4,5,6,7 
PEX5ΔN137 56.93 503 2,3,4,5,6,7 
PEX5ΔN147 54.87 492 3,4,5,6,7 
PEX5(C11K)10-324 35.37 317 0,1,2,3,4,5,6,7 
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Fig. 4 - PEX5 truncations for in vitro import/export assays.  
Deletion mutants of PEX5 were constructed by PCR using as template either PEX5L(C11K) or PEX5L(C11A) as 
indicated, the position 11 is specified in the representations (for more detail see experimental procedures section 3.1). 
cDNAs were purified and either directly used for in vitro transcription/translation (IVT) in a rabbit reticulocyte lysate (RRL) 
or cloned into E. coli expression vectors. The PEX5 residues contained in each deletion mutant are indicated. The 
truncations vary in the number of pentapeptide motifs (ranging from 0 to 7, blue) and in the presence of the TPRs motifs 
(orange, “TPRs”). The presence of 3 tandem methionines (M3) is represented in purple. 
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 PEX5ΔN137 is imported in a cargo-dependent manner  
As stated in the introduction section, insertion of PEX5 into the DTM is a cargo-
dependent event [75]. This property probably reflects the existence of an autoregulatory 
mechanism in PEX5 itself. Our hypothesis is that the C-terminal TPRs domain of PEX5 
is a cis-acting repressor of its N-terminal half, the domain where the DTM interacting 
motifs of PEX5 reside. We knew from previous work that a PEX5 protein lacking the first 
110 amino acids is still a robust substrate for the peroxisomal DTM. Importantly, insertion 
of this mutant PEX5 is cargo-protein dependent, implying that the first 110 amino acids 
residues of PEX5 are not part of this autoregulatory mechanism [73]. To better define 
the PEX5 region(s) involved in this mechanism, we used two truncated PEX5 molecules 
lacking larger N-terminal regions in in vitro import assays. The aim was two-fold: 1) to 
define the smallest PEX5 protein that is still import competent in a cargo-dependent 
manner; and 2) try to identify a PEX5 protein still capable of interacting with PTS1-
proteins and entering the DTM, but displaying the capacity to enter the DTM in a cargo-
independent manner. 
Three 35S-labelled PEX5 proteins were used in these experiments: PEX5L(C11K) 
as a positive control, PEX5ΔN137 and PEX5ΔN147 (see Fig. 4). In vitro import assays 
were done in the presence of rTPRs or rTPRs(N526K). rTPRs binds PTS1-cargo 
proteins present in the PNS but cannot be targeted to the peroxisomal membrane. Under 
these conditions, the 35S-labelled PEX5 reporter proteins cannot bind PTS1-proteins, 
and therefore do not become inserted into the DTM [75]. rTPRs(N526K) is virtually 
identical to rTPRs with the exception that it possesses a lysine instead of an asparagine 
at position 526. This missense mutation completely abolishes its PTS1-binding activity, 
and thus this protein is used as a negative control for rTPRs [59,116]. At the end of the 
import reaction, organelle suspensions were treated with a vast amount of proteinase K 
(PK). PK degrades all non-imported and non-specifically adsorbed radiolabelled 
proteins, whereas DTM inserted ones remain resistant [75,76,78,83]. 
As shown in Fig. 5, 35S-PEX5L(C11K) acquired a protease-protected status only in 
the assay lacking rTPRs, implying that this protein enters into the DTM in a cargo-
dependent manner, as expected (panel A, compare lanes “rTPRs” with 
“rTPRs(N526K)”). An identical result was obtained for 35S-PEX5ΔN137, clearly showing 
that this protein is also inserted into the DTM in a cargo-dependent manner (panel B). 
Note that more PK-resistant PEX5ΔN137 than PEX5(C11K) is detected in these 
experiments. This is due to the fact that N-terminally truncated PEX5 proteins lacking a 
ubiquitinatable residue at position 11 are export-incompetent [73]. For 35S-PEX5ΔN147 
a different result was obtained – no, or almost no, protein entered the DTM. We did detect 
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some signal after a very long exposure of the nitrocellulose membrane to an X-ray film. 
However, no evidence for cargo-dependence was obtained. (Note, that although the 
radioactive signal of 35S-PEX5ΔN147 is slightly stronger in the reaction performed in the 
presence of rTPRs(N526K) than in the presence of rTPRs, this difference is due to a 
larger protein load in former – see the Ponceau S stained membrane in panel C). 
Taken together, these results suggest that the first 137 amino acids of PEX5 are 
important neither for the docking/insertion of PEX5 into the DTM nor for its cargo-
dependent regulation. In addition, these results may suggest that amino acid residues 
138 to 147 of PEX5 are crucial for DTM insertion of PEX5 proteins containing their PTS1-
binding domain (TPRs). Unfortunately, the latter result also means that we could not 
identify a PEX5 protein shorter that PEX5ΔN137 that is still import-competent but now in 
a cargo-independent manner. 
 
 
Fig. 5 - Entry of 35S-PEX5ΔN137 in the peroxisomal membrane is a cargo-dependent process. 
Import reactions containing 600 µg of PNS protein were incubated with PEX5L(C11K) (A), 35S-PEX5ΔN137 (B) or 35S-
PEX5ΔN147 (C), ATP and rTPRs or rTPRs(N526K). After import, proteinase K-treated organelles were isolated and 
analysed by SDS-PAGE/autoradiography (X-ray – short is an exposure of 16 hours (B) or 4 days (A and C), X-ray – long 
is an exposure of 16 days). Lanes I, represent 10% of the 35S-PEX5 used in each reaction. 35S-PEX5, indicates the 
radiolabeled PEX5 protease-protected species after the in vitro import assay. Numbers on the left indicate the molecular 
mass of the protein standards in kDa.  
Note that for imported PEX5L(C11K), protease treatment results in two protease-protected species, namely stage 2 and 
stage 3 PEX5, which are indicated on the right (A). Recall from the introduction that stage 2 PEX5 represents DTM-
embedded PEX5 molecules that expose to the cytosol a N-terminal fragment. This region of PEX5 is clipped by PK, 
yielding a protein shorter by ca. 2 kDa. Stage 3 PEX5 represents the pool of monoubiquitinated DTM-embedded PEX5 
where the cytosolic N-terminal region of PEX5 is protected from the PK action and thus, no molecular wieght shift is 
observed. 
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 The first 117 amino acid residues of PEX5 are sufficient 
for its import and ubiquitination 
The interaction of PEX5 with DTM components involves the N-terminal half of 
PEX5 which contains the 8 pentapeptide repeats referred to previously (see introduction 
section 1.4) [34,112–114]. Indeed, this domain of PEX5 is crucial for its docking at and 
insertion into the DTM (see also introduction section 1.4). For example, PEX5 molecules 
lacking the TPRs domain but containing residues 1-197 or 1-324 of PEX5 are fully 
capable of being inserted into the DTMs as assessed by protease-protection 
experiments [75]. Interestingly, PEX5(1-197) contains just pentapeptide motifs 0 to 4. 
More recently, transfection experiments using CHO/HeLa cells led some authors to 
propose that a truncated PEX5 comprising just its first 158 amino acid residues is also 
functional in the interaction with the peroxisomal import machinery, although details on 
this interaction were not provided [123]. Aiming at defining the shortest PEX5 N-terminal 
fragment having the necessary and sufficient information to be 1) imported, 2) 
ubiquitinated, and 3) exported, we produced and characterized in vitro several C-
terminally truncated PEX5(C11K) proteins shorter than the ones described above. 
In addition to PEX5(C11K)1-324 and PEX5(C11K)1-197, used here as positive 
controls, seven different 35S-PEX5 proteins were studied. These differ mainly by the 
number of pentapeptide motifs they contain. Thus, PEX5(C11K)1-181 contains 
pentapeptides 0-3, PEX5(C11K)1-158 contains pentapeptides 0-2, PEX5(C11K)1-139 
and PEX5(C11K)1-125 contain pentapeptides 0-1, PEX5(C11K)1-117 contains only 
pentapeptide 0, and finally PEX5(C11K)1-61 contains no pentapeptide motifs (see Fig. 
4 for a graphical representation of all these molecules).  
In order to determine the import/ubiquitination ability of the above referred proteins 
we performed in vitro assays in the presence of AMP-PNP, an ATP analogue which can 
be used by the ubiquitin-conjugating cascade (UCC) but not by the receptor export 
module [97,124]. Under these conditions, import and ubiquitination of PEX5 proteins is 
rather efficient but their export is not possible, thus simplifying analysis of the results 
(only organelle pellets need to be analysed) [89]. Specific ubiquitination of PEX5 proteins 
was assessed in two different ways: 1) by a ca. 8 kDa increase in the apparent molecular 
mass of the PEX5 proteins upon SDS-PAGE when bovine ubiquitin was used in these 
assays; or 2) by a ca. 32 kDa increase when GST-Ub was used instead. (Note that GST-
Ub is also used efficiently by the UCC acting on PEX5. However, it results in PEX5 
species which are no longer substrates for the REM [84]).  
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As shown in Fig. 6, all C-terminally truncated PEX5 proteins but one were 
ubiquitinated in these assays; the exception was PEX5(C11K)1-61. Thus, a single 
pentapeptide motif, namely pentapeptide 0, seems to be sufficient to ensure that 
PEX5(C11K)1-117 enters the DTM and is monoubiquitinated. We still considered the 
possibility that PEX5(C11K)1-61 monoubiquitination might not be detectable in these 
assays due to the small number of methionines present in this PEX5 domain (the 
Fig. 6 - In vitro ubiquitination assay of C-terminal PEX5 truncations. 
Import reactions containing 600 µg of primed PNS protein were incubated with one of the following proteins 35S-
PEX5(C11K)1-324 (A), 35S-PEX5(C11K)1-197 (B), 35S-PEX5(C11K)1-181 (C), 35S-PEX5(C11K)1-158 (D), 35S-
PEX5(C11K)1-139 (E), 35S-PEX5(C11K)1-125 (F), 35S-PEX5(C11K)1-117 (G), 35S-PEX5(C11K)1-61 (H), 35S-
PEX5(C11K)1-61-M3 (I) in the presence of AMP-PNP and either ubiquitin (lanes Ub) or GST-Ubiquitin (lanes GST-Ub). 
Organelle pellets (P) were isolated and prepared for SDS-PAGE/autoradiography Lanes I, represent 10% of the 35S-
protein used in each reaction. a, Ub-PEX5 species. b, GST-Ub-PEX5 species. *, Ub-PEX5 modified with endogenous 
ubiquitin. h, haemoglobin from the RRL. Numbers on the left indicate the molecular mass of the protein standards in kDa. 
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radiolabelled amino acid used in our IVT is 35S-methionine and PEX5(C11K)1-61 
contains only 3 methionine residues). To exclude this, we produced a PEX5(C11K)1-61 
protein possessing 3 extra methionines at its C-terminus. As shown in Fig. 6 panel I, no 
specific ubiquitination of this PEX5 protein was observed. 
In short, we have narrowed down the minimum sequence of PEX5 necessary for 
its peroxisomal association (docking), insertion and monoubiquitination at the DTM to 
the amino acid residues 1 to 117. 
 Ub-PEX5(C11K)1-117 is a substrate for the receptor export 
module  
Recycling of DTM-embedded PEX5 back into the cytosol was shown to be 
dependent on: 1) the monoubiquitination of the receptor itself, and 2) hydrolysis of ATP 
[78,84,89]. These findings suggested that the AAA ATPases PEX1 and PEX6, the only 
two peroxins that bind and hydrolyse ATP, are involved in the extraction of Ub-PEX5 
from peroxisomal membranes [78,125]. However, on the actual mechanism used by the 
AAA ATPases to extract Ub-PEX5 not much is known. Thus, we reasoned that it would 
be interesting to know whether the small N-terminal PEX5 proteins characterized above 
and shown to be ubiquitinated are still substrates for the REM. These experiments might 
reveal the existence of PEX5 regions with no role in docking, insertion into the DTM and 
ubiquitination, but of crucial importance for the interaction between PEX5 and the REM. 
Anyway, even if it turns out that these PEX5 regions do not exist, assessment of the 
export-competence of those small N-terminal PEX5 proteins will lead to a better definition 
of the minimal domain of PEX5 that is necessary for the export step. (It should be noted 
that the shortest PEX5 protein, presently known, that is still functional in the import and 
export steps is PEX5(1-324) [73]).  
For this purpose, we subjected three of the small ubiquitinatable PEX5 proteins 
identified above, i.e., PEX5(C11K)1-117, PEX5(C11K)1-125 and PEX5(C11K)1-158, to 
in vitro reactions using experimental conditions in which export can or not occur (assays 
performed in the presence of ATP or AMP-PNP, respectively). HA-Ubal (or HA-Ub-VME) 
was included in these assays to protect exported (soluble) Ub-PEX5 proteins from the 
action of deubiquitinases present in the soluble phase of PNS [97]. These modified 
ubiquitin molecules are potent inhibitors of deubiquitinating enzymes [126].  
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As shown in Fig. 7 (panel A), 35S-PEX5(C11K)1-324 was monoubiquitinated both 
in the presence of ATP and AMP-PNP, but this PEX5 protein was only extracted from 
the DTM when ATP was available, as expected (compare lanes “P” and “S” under AMP-
PNP and ATP) [73,78]. Significantly, all the other tested PEX5 truncations, i.e., 35S-
PEX5(C11K)1-158, 35S-PEX5(C11K)1-125 and 35S-PEX5(C11K)1-117 (Fig. 7, panel B, 
C and D, respectively), were exported from the organelles in the in vitro import assays 
provided that export-permissive conditions were employed (compare organelle pellet “P” 
with supernatant “S” of ATP-containing reactions). Indeed, in the presence of AMP-PNP, 
all Ub-PEX5 species remained associated with the organelles, clearly showing that ATP 
hydrolysis is necessary to extract these PEX5 proteins from the DTM (compare lanes 
“P” and “S” under AMP-PNP) [78,84].  
These results, together with the observations made in section 4.3, indicate that 
amino acids 1-117 of PEX5 are sufficient for its peroxisome-cytosol trafficking. Thus, if 
there is indeed an interaction between PEX5 and the REM crucial for the PEX5 export, 
Fig. 7 - In vitro export of 35S-PEX5(C11K) C-terminal deletions. 
Import reactions containing 600 µg of primed PNS protein were incubated with 35S-PEX5(C11K)1-324 as a control (A), 
35S-PEX5(C11K)1-158 (B), 35S-PEX5(C11K)1-125 (C) or 35S-PEX5(C11K)1-117 (D), ubiquitin and HA-Ubal (A, B and C) 
or HA-Ub-VME (D). Each construct was imported in presence of AMP-PNP or ATP. After import, reactions were 
fractionated into an organelle pellet (P) and supernatant (S), and the equivalent to 100 µg of PNS protein was analysed 
by SDS-PAGE/autoradiography. Equivalents of 150 µg of PNS protein from the PEX5(C11K)1-117 reactions were 
loaded. Lanes I, represent 10% of the 35S-protein used in each reaction. , indicates monoubiquitinated PEX5. Numbers 
on the left indicate the molecular mass of the protein standards in kDa.  
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then this interaction involves some domain within the first 117 amino acid residues of 
PEX5. 
 The first 9 amino acid residues of PEX5 are not important 
for its function  
The alignment of the amino acid sequences of PEX5 from several organisms 
reveals a highly conserved C-terminal half (the TPRs containing domain which binds the 
PTS1 signal) and a highly divergent N-terminal domain [54]. In fact, besides the 
evolutionarily conserved cysteine and some pentapeptide motifs, the positioning of which 
varies substantially among organisms, not much else was evolutionary preserved. 
Nevertheless, sequence analysis of PEX5 proteins from Metazoa and also some Plants 
shows that the residues that precede the conserved cysteine residue at the N-terminus 
tend to be reasonably conserved (see Fig. 8). This property might suggest that these 
residues are functionally important. We know from previous studies that these N-
terminally located residues of PEX5 are not important for cargo-binding, docking at and 
insertion into the DTM, because a PEX5 protein lacking the first 110 amino acids is 
completely functional in all these steps [73]. However, they might be important for the 
interaction of PEX5 with the RING-ligase that monoubiquitinates it or, alternatively for 
the export step by providing a binding interface for the REM. We decided to address 
these possibilities. 
Firstly, we created a PEX5 protein lacking the first 9 amino acid residues, 
PEX5(C11K)10-324. The ability of this radiolabelled PEX5 protein to be 
monoubiquitinated and recycled back into the cytosol was then assessed in in vitro 
import/export experiments identical to the ones presented above (sections 4.3 and 4.4). 
Fig. 8 - Alignment of the PEX5 N-terminal domain containing the conserved cysteine from several organisms. 
The first amino acid residues of PEX5 from Homo sapiens (Hs) are aligned with the corresponding regions of PEX5 from
Xenopus tropicalis (Xt), Danio rerio (Dr), Arabidopsis thaliana (At), Drosophila melanogaster (Dm), Anopheles gambiae 
(Ag) and Caenorhabditis elegans (Ce). Residues conserved in four or more sequences are highlighted in blue. The 
invariable cysteine residue is in red. The PEX5 sequences were obtained from [129]. 
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In vitro assays were programmed with 35S-PEX5(C11K)10-324 or 35S-
PEX5(C11K)1-324, in the presence of AMP-PNP, and either Ub or GST-Ub. The results 
are shown in Fig. 9 (upper panels). Similarly to 35S-PEX5(C11K)1-324 (panel A), 35S-
PEX5(C11K)10-324 (panel B) was monoubiquitinated in these assays, as evidenced by 
the shift in the molecular weight of the ubiquitinated PEX5 species when GST-Ub was 
used (compare lanes “Ub” with lanes “GST-Ub”). Overall, these results suggest that the 
first 9 amino acids of PEX5(C11K) are not important for its import and, despite being 
adjacent to the modified residue (which in this case is a lysine), are also not required for 
PEX5 monoubiquitination in mammalian peroxisomes.  
We then assessed whether the first N-terminal residues of PEX5 are involved in 
the recognition and/or extraction of Ub-PEX5 by the REM. For this purpose, the 
subcellular localization of 35S-Ub-PEX5(6C11K)10-324 was examined following in vitro 
import assays done in the presence of either AMP-PNP or ATP. Fig. 9, panel D, shows 
Fig. 9 - Radiolabelled PEX5(C11K)10-324 is an import and export competent protein. 
A, B - Import reactions containing 600 µg of primed PNS protein were incubated with 35S-PEX5(C11K)1-324 (A) or 35S-
PEX5(C11K)10-324 (B) in the presence of AMP-PNP and either ubiquitin (lanes Ub) or GST-Ubiquitin (lanes GST-Ub). 
Organelle pellets (P) were isolated and prepared for SDS-PAGE/autoradiography. Lanes I, represent 10% of the 35S-
protein used in each reaction. a, represents Ub-PEX5 species; b, represents GST-Ub-PEX5 species. *, this band probably 
derives from an oxidative adduct of the 35S-proteins and the haemoglobin from the RRL. 
C, D - Import reactions containing 600 µg of primed PNS protein were incubated with 35S-PEX5(C11K)1-324 (C) or 35S-
PEX5(C11K)10-324 (D), ubiquitin and HA-Ubal. Each construct was imported in presence of AMP-PNP or ATP. After 
import, reactions were fractionated into an organelle pellet (P) and supernatant (S), and the equivalent to 100 µg of PNS 
protein was analysed by SDS-PAGE/autoradiography. Lanes I, represent 10% of the 35S-protein used in each reaction. 
, ubiquitinated PEX5 species.  
Numbers on the left indicate the molecular mass of the protein standards in kDa. 
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that in export-permissive conditions (i.e., ATP) 35S-Ub-PEX5(C11K)10-324 is recovered 
in the cytosolic fraction, behaving exactly as the control protein 35S-PEX5(C11K)1-324 
(panel C) [73,90].  
Altogether, these experiments indicate that the first 9 amino acids of human PEX5 
are not necessary for the transient passage of PEX5 through the peroxisomal 
docking/translocation module. Together with the results described in previous sections, 
we can conclude that the minimal PEX5 domain necessary and sufficient for DTM 
insertion, monoubiquitination and extraction back into the cytosol comprises amino acids 
10 to 117 of PEX5. 
 Membrane topology assessment of C-terminally truncated 
PEX5 molecules  
To better define the interaction between the DTM and the small N-terminal PEX5 
proteins characterized above, we decided to assess their membrane topologies using 
protease-protection assays. Recall that when full-length PEX5 is analysed using this 
methodology, two DTM-embedded PEX5 pools are discerned: 1) non-ubiquitinated 
PEX5 (the so-called stage 2 PEX5) from which only a 2 kDa N-terminal segment can be 
removed by the protease, and 2) monoubiquitinated PEX5 (stage 3 PEX5) which is 
completely resistant to the protease (see section 1.3.2.2 and 4.1) [76,78,83,84].  
We first tried to detect PK-resistant species in in vitro import assays programmed 
with 35S-PEX5(C11K)1-117 and 35S-PEX5(C11K)1-125 using standard conditions (i.e., 
incubation at 37 ºC in the presence of ATP followed by 30 minutes of proteolysis with 
400 µg/mL of PK). Intriguingly, we were unable to detect protease-resistant species (data 
not shown).  
We hypothesised that these negative results could be caused by the rapid export 
of these proteins from the DTM in the presence of ATP [84]. So, to increase the amount 
of PEX5 at the stage 2 level, we decreased the temperature of the in vitro assays to 26 
ºC. As previously shown, under these conditions the ubiquitin-conjugating cascade 
acting on PEX5 is particularly slowed down [73]. 
As shown in Fig. 10, protease treatment of organelles containing 35S-
PEX5(C11K)1-324 (panel A, lane “+PK”) revealed the presence of stage 2 and stage 3 
species, as expected. Note that the proteolysis conditions used in these assays are 
slightly different than the ones generally used in our laboratory [76]. Specifically, we 
decreased the incubation time with the protease given the problems in detecting 
protease-protected species for the small PEX5 proteins analysed in these assays. Thus, 
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instead of yielding a single species with the mass of the unmodified PEX5(C11K)1-324, 
some monoubiquitinated PEX5(C11K)1-324 remained intact after the protease 
incubation step. Unexpectedly, no protease-resistant species were detected in these 
experiments for 35S-PEX5(C11K)1-125 (panel B) and 35S-PEX5(C11K)1-117 (panel C). 
Apparently, DTM-embedded small N-terminal PEX5 fragments are accessible to the 
protease used in these experiments.  
To confirm these results, we repeated the protease-protection experiments with 
the C11A versions of some of the small N-terminal PEX5 fragments. The aim was to 
increase the amount of PEX5 proteins at the stage 2 level, and thus the sensitivity of our 
analysis (note that PEX5(C11A) proteins are not ubiquitinatable and thus accumulate 
massively at the DTM in in vitro assays supplemented with ATP; see section 4.1). As 
expected, 35S-PEX5(C11A)1-324 can be easily detected at the stage 2 level in these 
assays (see Fig. 11, panel A, compare lanes “+PK” with “-PK”). We were also able to 
detected some PEX5 at the stage 2 level when using 35S-PEX5(C11A)1-181 in these 
experiments. Intriguingly, two other proteinase K-resistant species were also detected 
(panel B, bands marked with “*”). We do not know the origin of these bands but current 
work in our laboratory is being carried out to clarify this issue. The three other proteins 
used in these experiments, namely PEX5(C11A)1-158, PEX5(C11A)1-139 and 
Fig. 10 - Protease-protection assay of 35S-PEX5(C11K) C-terminal truncations. 
Import reactions containing 600 µg of primed PNS protein were incubated for 30 minutes at 26 ºC with ATP and one of 
the following proteins 35S-PEX5(C11K)1-324 (A), 35S-PEX5(C11K)1-125 (B), 35S-PEX5(C11K)1-117 (C). After import, 
reactions were subjected (+PK) or not (-PK) to a protease-protection assay with proteinase K for 15 minutes. Organelles 
were isolated and analysed by SDS-PAGE/autoradiography. Lanes I, represent 2.5% of the 35S-protein used in each
reaction. Stage 2, represents DTM-embedded non-ubiquitinated PEX5 from which a 2 kDa fragment is degraded by PK. 
Stage 3, represents DTM-embedded Ub-PEX5, here the PK does not cleave the radiolabelled protein but probably the 
ubiquitin moiety that is attached to the N-terminal of PEX5, yielding a species that migrates as full-length PEX5. Ub-35S-
PEX5, monoubiquitinated radiolabelled PEX5 species. *, indicates radiolabelled products of the protease treatment that 
appear at the front of the gel irrespective of the 35S-PEX5 protein used in the assay. Numbers on the left indicate the 
molecular mass of the protein standards in kDa.  
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PEX5(C11A)1-125, yielded a negative result, that is, all were accessible to the protease. 
A possible explanation for this finding is provided in the discussion section. 
 Recombinant PEX5(C11K)1-125 obtained in E. coli 
BL21(DE3) 
As described above, both PEX5(C11K)1-125 and PEX5ΔN137 are import-
competent. Remarkably, these two proteins are non-superimposable, meaning they 
correspond to two non-overlapping PEX5 regions. Since PEX5(C11K)1-125, in contrast 
to PEX5ΔN137, is export-competent, we wondered whether we could accumulate the 
two proteins at the DTM using our in vitro assay, and if so, whether the export of 
PEX5(C11K)1-125 might drive extraction of the PEX5ΔN137 protein. A positive result in 
such an experiment would reveal important mechanistic details on the mechanism used 
by the REM to extract PEX5 from the DTM. For instance, one might conclude that the 
REM acts on the DTM components, sequestering them from PEX5, and not on PEX5 
itself; in such a scenario, ubiquitination of PEX5 would simply be the triggering signal to 
activate the REM and not a context-dependent handle for the export machinery.  
Fig. 11 - Protease-protection assay of PEX5(C11A) C-terminal deletion mutants. 
Import reactions containing 600 µg of primed PNS protein were incubated with ATP and one of the following proteins 35S-
PEX5(C11A)1-324 (A), 35S-PEX5(C11A)1-181 (B), 35S-PEX5(C11A)1-158 (C), 35S-PEX5(C11A)1-139 (D), 35S-
PEX5(C11A)1-125 (E). After import, reactions were subjected (+PK) or not (-PK) to a protease-protection assay with 
proteinase K for 30 minutes. Organelles were isolated and analysed by SDS-PAGE/autoradiography. Lanes I, represent 
5% of the 35S-protein used in each reaction. Stage 2, protease-resistant PEX5, indicated on the right; *, protease-resistant 
radiolabelled proteins for which no explanation can yet be advanced. Numbers on the left indicate the molecular mass of 
the protein standards in kDa. 
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To accomplish this aim, we needed to obtain large amounts of the PEX5(C11K)1-
125 protein. We first generated a pET-28a derived plasmid containing a cDNA encoding 
the PEX5(C11K)1-125 protein, pET-28a-His6-TEV-PEX5(C11K)1-125, which was 
transformed into E. coli BL21(DE3) cells. Although several experimental conditions were 
tested, we were unable to detect protein expression using this vector (data not shown). 
We suspected that the inability to produce recombinant PEX5(C11K)1-125 in E. 
coli cells was due to its instability, probably derived from a combination of its small size 
and its natively unfolded structure. In an attempt to bypass this problem, we decided to 
express PEX5(C11K)1-125 as a fusion protein with SUMO3 (small ubiquitin-like modifier 
3). This strategy improved significantly the amount of recombinant protein produced in 
these cells (see Fig. 12, panel A and B). However, the fusion protein was clearly very 
Fig. 12 - Production of recombinant PEX5(C11K)1-125. 
A - Induction of the His6-SUMO3-PEX5(C11K)1-125 protein expression was performed with 1 mM IPTG for 2 hours at 37 
ºC. Aliquots equivalent to 100 µL of non-induced (NI) and induced (I) culture were analysed on SDS-PAGE; a and b
indicate the induced proteins. 
B - Anti-His immunoblot of 100 µL of non-induced (NI) and induced (I) cultures with 1 mM IPTG for 3 hours at 37 ºC. 
C - Purification of His6-SUMO3-PEX5(C11K)1-125 from E. coli cell extracts by Ni
2+-NTA affinity chromatography. 
Equivalents to 100 µL of culture were removed at different steps of the purification procedure, separated by SDS-PAGE, 
transferred onto a nitrocellulose membrane and stained with Ponceau S. Total, sonicated cells in lysis buffer; I. bodies, 
inclusion bodies recovered after centrifugation of the total sonicated cell lysate; Supernatant, soluble fraction of the total 
sonicated cell lysate; N. bound, non-bound fraction of the chromatography; Elution, aliquots removed after elution of the 
Ni-NTA beads; LMW, low molecular weight marker (BioRad); Concentrated protein, the final protein solution was 
successively diluted (as indicated); Wash, fractions resultant of washing the beads in buffer. 
D - Digestion with cSENP2. 1.2 mg of His6-SUMO3-PEX5(C11K)1-125 was cleaved with 1.2 µg of cSENP2 for 1 hour at 
25 ºC. Aliquots equivalent to 2 µg of non-digested (ND) and digested (D) samples were run on SDS-PAGE, transferred 
onto a nitrocellulose membrane and stained with Ponceau S. The action of the SUMO protease gives rise to three new 
protein bands: *1, *2 and *3. 
E - Cleaved His6-SUMO3 was removed by Ni
2+-NTA chromatography (*1, Beads) and our protein of interest, 
PEX5(C11K)1-125, was recovered in the unbound fraction (*2 and *3, NB).  
Numbers on the left indicate the molecular mass of the protein standards in kDa.  
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heterogeneous, the result of proteolysis acting on the PEX5 moiety (see Fig. 12, panel 
C, D and E). Furthermore, after cleaving the fusion protein with cSENP2 to remove the 
SUMO3 tag, we realized that the largest PEX5 fragment that we could detect was 1-2 
kDa shorter than the 35S-PEX5(C11K)1-125 protein obtained by IVT (see Fig. 13). Thus, 
we decided not to pursue these experiments further.  
 
 
Fig. 13 - Recombinant PEX5(C11K)1-125 suffers proteolysis in E. coli BL21(DE3) cells. 
Protein mixtures were analysed by SDS-PAGE and autoradiography. As indicated, either 1 µL of recombinant protein
(which corresponds to ca. 0.7 µg of the 14 kDa protein) and/or 0.05 µL of 35S-PEX5(C11K)1-125 were mixed and loaded. 
After staining with Ponceau S, the membrane was exposed overnight with an x-Ray film. The migration of the radioactive 
PEX5 is indicated with ◄. *, corresponds to the haemoglobin present in the rabbit reticulocyte lysate. Numbers on the 
left indicate the molecular mass of the protein standards in kDa. 
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Shuttling of the peroxisomal protein import receptor PEX5 between the cytosol and 
the organelle is an ATP hydrolysis requiring process [78]. Therefore, it is not surprising 
that the pathway is regulated and that only cargo-loaded PEX5 has access to the 
peroxisomal DTM [75]. As explained before (see Introduction section 1.4), several data 
suggest that this regulatory mechanism resides in PEX5 itself. All the presently available 
data indicate that the PEX5 C-terminal half is a cis-acting repressor of its N-terminal half 
(the region containing the DTM interacting motifs) but the molecular details behind this 
interaction remain unknown [75,116]. Our hypothesis is that the cargo-free C-terminal 
half of PEX5 interacts (and inactivates) the N-terminal half of PEX5, and that this 
interaction is disrupted when a cargo binds to the C-terminal domain of PEX5. We knew 
from previous work that the first 110 amino acids of PEX5 cannot be involved in this 
hypothetical cross-talk [73]. Indeed, as shown by Costa-Rodrigues et al., PEX5ΔN110 is 
still import-competent in a cargo-dependent manner. In our work, we extended these 
studies by characterizing PEX5 proteins lacking larger N-terminal domains, namely 
PEX5ΔN137 and PEX5ΔN147. The results of this characterization are discussed below. 
Our data show that PEX5ΔN137 is still able to insert into the DTM in a cargo-
dependent manner. Thus, we can conclude that the first 137 amino acids of PEX5 are 
important neither for the insertion of the receptor into the DTM nor for its autoregulatory 
mechanism. This means that pentapeptide motifs 0 and 1 are required for none of these 
two processes. Rather different results were obtained for PEX5ΔN147. Indeed, this 
protein is no longer import-competent. Apparently, shortening PEX5ΔN137 by just 10 
amino acid residues at its N-terminus completely abolishes its ability to interact with the 
DTM. 
The fact that PEX5ΔN147 is no longer import-competent impedes us from drawing 
any conclusions regarding the cross-talk between the N- and C-terminal halves. 
Nevertheless, this property of PEX5ΔN147 might suggest that amino acid residues 138 
to 147, where pentapeptide motif 2 is present, are precisely the N-terminal half region 
involved in the aforementioned cross-talk. Considering that pentapeptide 0 per se seems 
to be sufficient to target PEX5 to the DTM (see below), we could test our hypothesis by 
producing a full-length PEX5 protein having amino acid residues 138-147 substituted by 
alanines and determine whether this protein is import-competent but now in a cargo-
independent manner. 
The reason why PEX5ΔN147 is not import competent is intriguing; after all, this 
protein still contains pentapeptide motifs 3 to 7 which, in principle, might still sustain 
insertion of PEX5 into the DTM. However, as proposed before it is possible that the 
different pentapeptide motifs in PEX5 have different functions. For instance, some motifs 
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might be involved in the docking/insertion steps whereas others might be required for 
cargo-release [82]. In this scenario, our results indicate, on one hand that for the TPRs-
containing PEX5 protein lacking pentapeptide motif 0 and 1 used in our study, 
pentapeptide motif 2 is crucial for the docking/insertion steps, and on the other hand that 
pentapeptide motifs 3-7 are unable to promote insertion of this PEX5 truncated protein 
into the DTM.  
It is well established that the N-terminal half of PEX5 is crucial for its function as a 
shuttling receptor: it is through this region that PEX5 interact with all the components of 
the PIM, as shown by the finding that proteins such as PEX5(1-324) are fully competent 
in the docking, insertion, monoubiquitination and export steps whereas PEX5 proteins 
lacking the N-terminal half (e.g., PEX5(324-639)) are completely incompetent at the very 
first step occurring at the peroxisome, i.e., docking [unpublished,74,90]. 
In this work, we wanted to define the minimal domain of PEX5 functional in all of 
the steps occurring at the peroxisomal membrane. For this purpose, we produced 
several PEX5 C-terminally truncated proteins and characterized their behaviour in in vitro 
import/export assays. The results of these experiments and their implications are 
addressed below. 
First, we found out that PEX5(C11K)1-117, a PEX5 truncated protein containing 
solely pentapeptide motif 0, still retains the capacity to enter the DTM and be 
monoubiquitinated. We also showed that a PEX5 protein without the TPRs domain and 
lacking the first 9 amino acid residues (i.e., PEX5(C11K)10-324)) is still competent in the 
docking, insertion and monoubiquitination steps. Thus, these two observations indicate 
that the capacity to enter the DTM and be monoubiquitinated resides in the PEX5 domain 
comprising amino acid residues 10 to 117. We note that the monoubiquitination efficiency 
of PEX5(C11K)1-117 observed in our in vitro assays is lower than, for example, that 
detected with PEX5(C11K)1-324. This can be explained by the fact that human PEX5 
contains several binding sites for PEX14, some of which are probably autonomous 
elements in the docking/insertion steps, whereas PEX5(C11K)1-117 contains only one 
PEX14 binding site, pentapeptide 0, with this capacity [77,113,114]. In other words, the 
existence of multiple PEX14 binding sites in PEX5 probably translates into faster 
association rates of this protein with the DTM because many more collisions between 
these two molecular entities will be productive. 
Although PEX5(C11K)1-117 contains only one pentapeptide motif, its interaction 
with the DTM seems to be quite strong. Indeed, in the ubiquitination experiments showed 
(Fig. 7, panel D) no, or almost no, monoubiquitinated PEX5(C11K)1-117 can be detected 
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in the supernatant fraction of in vitro assays when AMP-PNP is used; only in the 
presence of ATP is this monoubiquitinated species exported into the soluble phase of 
the assays.  
The mechanism used by the REM to extract PEX5 from the DTM remains largely 
unknown. From a conceptual point of view, there are two non-mutually exclusive 
possibilities (see Fig. 14) [127]. In one, the REM would bind Ub-PEX5 and would pull it 
from the DTM (panel A). In the other, the REM might disassemble the Ub-PEX5-DTM 
protein complex by interacting with and sequestering the membrane peroxins from the 
DTM that interact with PEX5 (panel B). Although our results are compatible with both 
models, the fact that monoubiquitinated PEX5(C11K)1-117 is exported in our assays has 
implications for the mechanism used by the REM to extract DTM-embedded PEX5 into 
the cytosol. For instance, it is now clear that the REM is not activated by some cargo-
induced rearrangement of DTM components occurring when cargo-loaded PEX5 enters 
the DTM. Evidently, a PEX5 protein lacking any cargo-binding capacity can also activate 
and be extracted by the REM as long as it contains a ubiquitinatable residue at position 
11 [75,89]. Also, our results suggest that amino acid residues 118-639 of PEX5 do not 
Fig. 14 - Possible mechanisms used by the REM to extract Ub-PEX5(C11K)1-117 from peroxisomal membranes. 
A - Ubiquitinated (bright green shape) PEX5 (orange line) is directly or indirectly recognized by the REM (blue complex). 
This recognition event possibly leads to an interaction between the REM and a loop of PEX5 contained in its first 117 
amino acid residues. By coupling ATP hydrolysis to mechanical strength, the REM peroxins pull this PEX5 loop by a 
threading motion that ultimately results in Ub-PEX5 extraction. This mode of operation is similar to the AAA ATPase   
p97/VCP (Valosin-containing protein) which is responsible for the extraction of polyubiquitinated misfolded proteins from 
the endoplasmic reticulum [130]. B - Ubiquitinated (bright green shape) PEX5 (orange line) is directly or indirectly 
recognized by the REM (blue complex). This recognition event might lead to an interaction between the REM and the 
DTM (membrane-embedded grey complex). In this case, ATP hydrolysis is coupled to the mechanical strength exerted 
over the DTM, which leads to conformational alterations in the DTM that result in expulsion of Ub-PEX5 to the soluble 
fraction. This mode of action is related to the AAA ATPase NSF (N-ethylmaleimide sensitive factor) which disassembles 
the protein complex SNARE (soluble N-ethylmaleimide sensitive factor attachment receptor) after membrane fusion 
events [131].  
The purple star represents the pentapeptide motif contained in PEX5(C11K)1-117. 
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establish crucial interactions with the REM. Apparently, at the very best only residues 
10-117 of PEX5 are required for the export step. 
The fact that PEX5(C11K)1-117 is monoubiquitinated and a substrate for the REM 
strongly suggests that this truncated version of PEX5 enters the DTM acquiring a normal 
topology. However, we were surprised by the finding that no protease-protected 
PEX5(C11K)1-117 was detected in our experiments. (As explained in detail in the 
introduction section, DTM-embedded PEX5 species are mostly resistant to proteinase K 
with the exception that 2 kDa of their N-terminus is removed by the protease, see Fig. 
15, upper panel [75,78]). Moreover, exactly the same results were obtained for 
PEX5(C11A)1-125, PEX5(C11A)1-139 and PEX5(C11A)1-158 – none of these proteins 
displayed resistance to the protease in our in vitro assays. Although additional 
experiments must be performed to fully clarify these findings, there are two plausible 
explanations for our data (see Fig. 15, lower panel). One possibility is that cleavage of 
the cytosolic-exposed domains of the DTM components by proteinase K, weakens the 
architecture of the module, thus disrupting the interaction with PEX5(1-117) (see Fig. 15, 
lower panel, A) [77]. The other possibility is that proteinase K can enter the DTM 
whenever this membrane complex is occupied with the very small C-terminally truncated 
PEX5 proteins used in our study (see Fig. 15, lower panel, B). The latter possibility is 
Fig. 15 - Molecular representation of a protease-
protection assays after in vitro import of 35S-
PEX5 proteins. 
Upper panel - In vitro imported full-length PEX5 or 
PEX5 amino acid residues 1-324 into intact 
peroxisomes, expose a small N-terminal fragment 
of ca. 2 kDa into the cytosol (in orange, the line 
represents the natively unfolded N-terminal domain 
and the sphere symbolises the TPRs domain). This 
region of PEX5 is susceptible to proteinase K (PK, 
in red) and is degraded. However, a significant part 
of PEX5 remains protease protected inside the 
DTM (grey membrane complex). 
Lower panel - In vitro imported small C-terminally 
truncated PEX5 proteins (PEX5(1-117), PEX5(1-
125), PEX5(1-139), PEX5(1-158), orange line) into 
intact peroxisomes, are totally susceptible to 
proteinase K (PK, in red), which can be explained 
by two possibilities. A, the protease degrades all 
the cytosol-exposed fragments of DTM peroxins. 
This disturbs the DTM stability and might lead to the 
disruption of the interaction between the small 
PEX5 proteins and the DTM. The PEX5 proteins 
now in the soluble fraction are degraded by PK. B, 
the protease enters in the DTM and degrades the 
small DTM-embedded PEX5 proteins. Note that 
proteinase K might enter because it is a globular 
protein with a radius of ca. 20.2 nm, whereas, for 
example, the PEX5 TPRs domain (one of the 
regions lacking in our small C-terminally PEX5 
truncated proteins) can be approximated to a 
sphere with a radius of ca. 21.5 nm. 
The purple stars represent the PEX5 pentapeptide 
motifs. 
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particularly interesting because it suggests that the DTM is a bowl-shaped cavity with a 
fixed geometry, which is fully filled by an intact PEX5 molecule, but only partially by the 
small PEX5 proteins used by us. In other words, the DTM would resemble more a mini-
nuclear-pore(NPC)-complex and not the dynamic pore assembled on demand found in 
twin-arginine translocation (TAT) systems of bacteria and chloroplasts [128]. Future 
experiments need to be done to clarify this important aspect of the PIM. 
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